Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Daniel Morgensztern | Researchclopedia

Back to researchers

Daniel Morgensztern

Hebron University ORCID

435

Works

20,259

Citations

50

h-index

136

i10-index

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment

Affiliations

Hebron University2026–2026

Novartis (Switzerland)2015–2015

Barnes-Jewish Hospital2006–2025

St. Louis Children's Hospital2007–2007

University of Miami2002–2008

Top Works

The biology and management of non-small cell lung cancer

Roy S. Herbst,Daniel Morgensztern,et al.

20184,837 citations

Cancer Immunotherapy and Biomarkers

Cancer Genomics and Diagnostics

Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database

Ramaswamy Govindan,Nathan Page,et al.

20061,842 citations

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S. Ettinger,Douglas E. Wood,et al.

20221,386 citations

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021

David S. Ettinger,Douglas E. Wood,et al.

2021996 citations

Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas

Bryan Oronsky,C. Patrick,et al.

2017739 citations

Non–Small Cell Lung Cancer, Version 4.2024

Gregory J. Riely,Douglas E. Wood,et al.

2024657 citations

Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey

Daniel Morgensztern,Shean Huey Ng,et al.

2010545 citations

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study

Charles M. Rudin,M. Catherine Pietanza,et al.

2016544 citations

PI3K/Akt/mTOR pathway as a target for cancer therapy

Daniel Morgensztern,Howard L. McLeod

2005464 citations